Matthew D. Hall

Pediatric and adult H3 K27M-mutant diffuse midline glioma treated with the selective DRD2 antagonist ONC201

Rohinton S. Tarapore, Matthew D. Hall, Nicole Shonka et al. · Journal of Neuro-Oncology · 2019 · 197 citations

Medicine, Oncology, Pharmacology +9

Ablative 5-Fraction Stereotactic Magnetic Resonance–Guided Radiation Therapy With On-Table Adaptive Replanning and Elective Nodal Irradiation for Inoperable Pancreas Cancer

Michael D. Chuong, John Michael Bryant, Kathryn E. Mittauer et al. · Practical Radiation Oncology · 2020 · 175 citations

Medicine, Oncology, Radiation Oncology +15

Clinical Efficacy of ONC201 in H3K27M-Mutant Diffuse Midline Gliomas Is Driven by Disruption of Integrated Metabolic and Epigenetic Pathways

Sriram Venneti, Abed Rahman Kawakibi, Sunjong Ji et al. · Cancer Discovery · 2023 · 154 citations · Full text

Medicine, Cancer Biology, Oncology +14

First clinical experience with DRD2/3 antagonist ONC201 in H3 K27M–mutant pediatric diffuse intrinsic pontine glioma: a case report

Matthew D. Hall, Yazmín Odia, Joshua E. Allen et al. · Journal of Neurosurgery Pediatrics · 2019 · 90 citations

Medicine, Oncology, Pharmacology +17

Elective resection of 332 abdominal aortic aneurysms in a southern West Virginia community during a recent five-year period.

Ali F. AbuRahma, P. A. Robinson, James P. Boland et al. · PubMed · 1991 · 69 citations

Medicine, Surgery, Cardiothoracic Surgery +8